Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$438M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$309M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$274M |
| 4 |
PepsiCo
PEP
|
+$229M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$752M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$448M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Healthcare | 5.4% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 4.64% |
| 5 | Industrials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Goosehead Insurance
GSHD
$2.2B
| $679K | ﹤0.01% |
9,105
+2,148
| +31% | +$144K |
|
2727
NeoGenomics
NEO
$1.96B
| $678K | ﹤0.01% |
55,129
-44,011
| -44% | -$654K |
|
2728
Levi Strauss
LEVI
$9.44B
| $677K | ﹤0.01% |
49,879
+14,295
| +40% | +$200K |
|
|
MDRX
2729
DELISTED
Veradigm Inc. Common Stock
MDRX
| $677K | ﹤0.01% |
51,493
-56,233
| -52% | -$737K |
|
2730
Apogee Enterprises
APOG
$826M
| $676K | ﹤0.01% |
14,354
-17,152
| -54% | -$834K |
|
2731
Black Stone Minerals
BSM
$3.18B
| $676K | ﹤0.01% |
39,218
+38,821
| +9,779% | +$662K |
|
2732
Virtu Financial
VIRT
$5.11B
| $676K | ﹤0.01% |
39,117
-16,197
| -29% | -$294K |
|
2733
Progyny
PGNY
$2.44B
| $674K | ﹤0.01% |
19,821
-27,481
| -58% | -$1.04M |
|
2734
Ecopetrol
EC
$34.5B
| $674K | ﹤0.01% |
58,220
+9,878
| +20% | +$113K |
|
|
AAT
2735
American Assets Trust
AAT
$1.45B
| $673K | ﹤0.01% |
34,612
-5,537
| -14% | -$116K |
|
2736
ProShares Nasdaq-100 Dorsey Wright Momentum ETF
QQQA
$69.9M
| $672K | ﹤0.01% |
20,008
| – | – |
|
2737
America Movil
AMX
$76.1B
| $671K | ﹤0.01% |
38,763
-21,478
| -36% | -$420K |
|
2738
Atara Biotherapeutics
ATRA
$75.5M
| $671K | ﹤0.01% |
18,124
-1,146
| -6% | -$51K |
|
2739
Bloom Energy
BE
$60.6B
| $668K | ﹤0.01% |
50,383
-93,955
| -65% | -$1.47M |
|
2740
Avient
AVNT
$3.33B
| $668K | ﹤0.01% |
18,913
-22,995
| -55% | -$891K |
|
2741
Cognyte Software
CGNT
$659M
| $667K | ﹤0.01% |
138,749
+3,993
| +3% | +$20.3K |
|
|
JAMF
2742
DELISTED
Jamf
JAMF
| $667K | ﹤0.01% |
37,780
-31,953
| -46% | -$593K |
|
|
PNT
2743
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $665K | ﹤0.01% |
99,775
+17,913
| +22% | +$149K |
|
2744
Southside Bancshares
SBSI
$967M
| $665K | ﹤0.01% |
23,169
-13,630
| -37% | -$406K |
|
2745
Valvoline
VVV
$4.9B
| $665K | ﹤0.01% |
20,615
-4,825
| -19% | -$170K |
|
2746
Vanguard Materials ETF
VAW
$2.95B
| $665K | ﹤0.01% |
3,852
-910
| -19% | -$164K |
|
2747
CALL
Louisiana-Pacific
LPX
$5.06B
| $663K | ﹤0.01% |
+12,000
| New | +$788K |
|
|
ACH
2748
Accendra Health
ACH
$237M
| $663K | ﹤0.01% |
41,007
-31,299
| -43% | -$555K |
|
2749
National Grid
NGG
$80.4B
| $661K | ﹤0.01% |
11,574
+5,307
| +85% | +$321K |
|
2750
Lumen
LUMN
$6.57B
| $660K | ﹤0.01% |
465,100
-551,621
| -54% | -$934K |
|
Similar funds
Citigroup's Q3 2023 Portfolio in Review
As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.
- Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
- Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
- Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
- Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
- Citigroup opened 337 new positions and closed 265 in Q3 2023.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.